UNIGE document Scientific Article
previous document  unige:39101  next document
add to browser collection
Title

Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial

Authors
Published in Cancer Journal. 2005, vol. 11, no. 2, p. 133-9
Abstract The purpose of this study was to determine the maximum tolerated dose of gemcitabine when it was administered concomitantly with hyperfractionated radiotherapy before surgery in patients with locally advanced rectal cancers and to investigate the midterm efficacy of such a regimen.
Keywords AdultAgedDeoxycytidine/administration & dosage/adverse effects/analogs & derivatives/therapeutic useDose FractionationFemaleHumansMaleMiddle AgedNeoplasm StagingPreoperative CareRadiation-Sensitizing Agents/administration & dosage/adverse effects/therapeutic useRadiotherapy, AdjuvantRadiotherapy, ConformalRectal Neoplasms/drug therapy/pathology/radiotherapySurvival AnalysisTime FactorsTreatment Outcome
Identifiers
PMID: 15969988
Full text
Structures
Research groups Chirurgie viscérale (104)
Groupe Roth Arnaud (oncologie) (285)
Citation
(ISO format)
ALLAL, Abdelkarim Said et al. Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial. In: Cancer Journal, 2005, vol. 11, n° 2, p. 133-9. https://archive-ouverte.unige.ch/unige:39101

186 hits

0 download

Update

Deposited on : 2014-08-04

Export document
Format :
Citation style :